Strattera (TN)

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

53 API Suppliers, 17 USDMF, 9 CEP/COS, 6 JDMF, 16 EU WC, 16 KDMF, 18 NDC API, 24 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

365 FDF Dossiers, 77 FDA Orange Book, 99 Europe, 66 Canada, 14 Australia, 49 South Africa, 60 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG BASE, CAPSULE;ORAL - EQ 10MG BASE, CAPSULE;ORAL - EQ 18MG BASE, CAPSULE;ORAL - EQ 25MG BASE, CAPSULE;ORAL - EQ 40MG BASE, CAPSULE;ORAL - EQ 60MG BASE, CAPSULE;ORAL - EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 9 DKSH, 2 Faran Shimi Pharmaceutical, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 1 Finar, 2 Gangwal Chemicals, 2 Ingredion Pharma Solutions, 1 Kerry, 3 Lonza Capsugel, 2 Pluviaendo, 1 Qualicaps, 8 Roquette, 2 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Sigachi Industries, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 9 Coating Systems & Additives, 8 Thickeners and Stabilizers, 8 Empty Capsules, 7 Direct Compression, 6 Taste Masking, 4 Lubricants & Glidants, 4 Film Formers & Plasticizers, 4 Granulation, 4 Topical, 3 Co-Processed Excipients, 3 Disintegrants & Superdisintegrants, 3 Coloring Agents, 3 Emulsifying Agents, 3 Chewable & Orodispersible Aids, 2 Solubilizers, 2 Controlled & Modified Release, 1 Parenteral, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers